• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹腔镜脾切除术作为上皮性输卵管卵巢癌孤立性脾实质复发的四级细胞减灭术:1例报告及文献复习

Laparoscopic Splenectomy as Quaternary Cytoreduction for Isolated Parenchymal Splenic Recurrence of Epitelial Tubo-Ovarian Cancer: Report of a Case and Literature Review.

作者信息

Sorbi Flavia, Prosperi Paolo, Villanucci Alessandro, Berti Valentina, Sisti Giovanni, Fambrini Massimiliano

机构信息

Department of Biomedical, Experimental and Clinical Sciences, Division of Obstetrics and Gynecology, University of Florence, Florence, Italy.

出版信息

Gynecol Obstet Invest. 2015;80(4):265-71. doi: 10.1159/000366476. Epub 2015 Feb 10.

DOI:10.1159/000366476
PMID:25677585
Abstract

Isolated parenchymal splenic lesions are very rare and may occur as recurrences in the form of epithelial tubo-ovarian cancer (ETOC). We report a case of solitary parenchymal splenic recurrence of ETOC, which developed 50 months after the initial treatment. A 66-year-old woman underwent laparotomic primary cytoreduction in 2008. After platinum-based chemotherapy, she developed recurrences; thus, she underwent secondary and tertiary cytoreduction in 2011 and 2012 respectively. In April 2013, CT scan documented a solitary parenchymal splenic lesion and it was confirmed by FDG PET/CT. She underwent quaternary cytoreduction by laparoscopic splenectomy. Histopathological evaluation revealed metastatic parenchymal disease consistent with recurrent ETOC. She was alive and disease-free for ten months since splenectomy. In literature there are 35 cases of isolated spleen parenchymal metastasis of ETOC and our report is the first case of laparoscopic splenectomy in the setting of quaternary cytoreduction. Laparoscopic splenectomy as quaternary cytoreduction is safe and feasible and could be congruent to the well-established experiences already reported for the primary, secondary or even tertiary cytoreduction where the absence of residual disease has been translated in a significant survival benefit.

摘要

孤立性脾实质病变非常罕见,可能以上皮性输卵管卵巢癌(ETOC)复发的形式出现。我们报告一例ETOC孤立性脾实质复发病例,该病例在初始治疗50个月后出现。一名66岁女性于2008年接受剖腹探查初次肿瘤细胞减灭术。在接受铂类化疗后,她出现复发;因此,她分别于2011年和2012年接受了二次和三次肿瘤细胞减灭术。2013年4月,CT扫描发现一个孤立性脾实质病变,FDG PET/CT证实了这一病变。她接受了腹腔镜脾切除术进行四次肿瘤细胞减灭术。组织病理学评估显示转移性脾实质疾病,与复发性ETOC一致。自脾切除术后,她存活且无病生存了十个月。文献中有35例ETOC孤立性脾实质转移病例,我们的报告是首例在四次肿瘤细胞减灭术背景下进行腹腔镜脾切除术的病例。腹腔镜脾切除术作为四次肿瘤细胞减灭术是安全可行的,并且可能与已报道的关于初次、二次甚至三次肿瘤细胞减灭术的成熟经验一致,在这些手术中,无残留疾病已转化为显著的生存获益。

相似文献

1
Laparoscopic Splenectomy as Quaternary Cytoreduction for Isolated Parenchymal Splenic Recurrence of Epitelial Tubo-Ovarian Cancer: Report of a Case and Literature Review.腹腔镜脾切除术作为上皮性输卵管卵巢癌孤立性脾实质复发的四级细胞减灭术:1例报告及文献复习
Gynecol Obstet Invest. 2015;80(4):265-71. doi: 10.1159/000366476. Epub 2015 Feb 10.
2
Laparoscopic splenectomy for solitary splenic metastasis in a patient with ovarian cancer with a long disease-free interval: a case report.腹腔镜脾切除术治疗卵巢癌伴长无病生存期患者的孤立性脾转移:一例报告
J Med Case Rep. 2018 May 15;12(1):132. doi: 10.1186/s13256-018-1673-4.
3
Laparoscopic Splenectomy for Secondary Cytoreduction in Ovarian Cancer Patients With Localized Spleen Recurrence: Feasibility and Technique.腹腔镜脾切除术用于卵巢癌局部脾脏复发患者的二次细胞减灭术:可行性与技术
J Minim Invasive Gynecol. 2016 Mar-Apr;23(3):425-8. doi: 10.1016/j.jmig.2016.01.001. Epub 2016 Jan 8.
4
Splenectomy as Part of Cytoreductive Surgery in Recurrent Epithelial Ovarian Cancer.脾切除术作为复发性上皮性卵巢癌细胞减灭术的一部分
Anticancer Res. 2015 Sep;35(9):5097-101.
5
Laparoscopic splenectomy for isolated parenchymal splenic metastasis of ovarian cancer.腹腔镜脾切除术治疗卵巢癌孤立性脾实质转移
Int J Gynecol Cancer. 2006 Sep-Oct;16(5):1933-5. doi: 10.1111/j.1525-1438.2006.00662.x.
6
Solitary parenchymal splenic recurrence of ovarian adenocarcinoma: a case report and review of the literature.卵巢腺癌孤立性脾实质复发:一例报告并文献复习
Anticancer Res. 2005 Mar-Apr;25(2B):1471-6.
7
Distal pancreatectomy with splenectomy for the management of splenic hilum metastasis in cytoreductive surgery of epithelial ovarian cancer.远端胰腺切除术联合脾切除术用于上皮性卵巢癌减瘤手术中脾门转移灶的处理。
J Gynecol Oncol. 2016 Nov;27(6):e62. doi: 10.3802/jgo.2016.27.e62. Epub 2016 Aug 2.
8
Laparoscopic splenectomy for secondary cytoreduction of ovarian cancer in a woman with localized splenic recurrence.腹腔镜脾切除术治疗局部复发性卵巢癌的女性二次细胞减灭术。
Gynecol Oncol. 2020 Mar;156(3):744-745. doi: 10.1016/j.ygyno.2019.12.021. Epub 2020 Jan 16.
9
Solitary splenic recurrence of epithelial ovarian cancer: a case report and review.上皮性卵巢癌孤立性脾脏复发:一例报告及文献复习
Anticancer Res. 2002 Nov-Dec;22(6B):3643-5.
10
Splenectomy in recurrent epithelial ovarian cancer.复发性上皮性卵巢癌的脾切除术
Gynecol Oncol. 1999 Mar;72(3):407-10. doi: 10.1006/gyno.1998.5141.

引用本文的文献

1
Upgrade of an old drug: Auranofin in innovative cancer therapies to overcome drug resistance and to increase drug effectiveness.老药升级:金诺芬在创新癌症疗法中克服耐药性和提高药物疗效。
Med Res Rev. 2022 May;42(3):1111-1146. doi: 10.1002/med.21872. Epub 2021 Dec 1.
2
Laparoscopic splenectomy for solitary splenic metastasis in a patient with ovarian cancer with a long disease-free interval: a case report.腹腔镜脾切除术治疗卵巢癌伴长无病生存期患者的孤立性脾转移:一例报告
J Med Case Rep. 2018 May 15;12(1):132. doi: 10.1186/s13256-018-1673-4.